Category: biotech

.Monopar Therapeutics is recouping a medication coming from the scrap heap of AstraZeneca’s unusual condition pipe. It has licensed ALXN-1840, an applicant for the treatment

.AN2 Rehabs is reassessing its service in response to dull midphase information, vowing to lay off half its own employees and quit a period 3

.ALX Oncology’s period 2 gastric cancer feedback price has actually weakened. After seeing its CD47 blocker quickly beat management over the very first half of

.After greater than 20 years of focus on neurodegenerative conditions, Swiss biotech air conditioner Immune cases it could possess a game changer on its own